NeuBase Therapeutics Inc

NASDAQ:NBSE   9:51:58 AM EDT
3.98
+0.01 (+0.25%)
Earnings Announcements

Neubase Therapeutics Reports Financial Results For The Third Quarter Of Fiscal Year 2021 And Recent Operating Highlights

Published: 08/12/2021 20:51 GMT
NeuBase Therapeutics Inc (NBSE) - Neubase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights.
Q3 Loss per Share $0.29.
Q3 Earnings per Share Estimate $-0.21 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.